ITM - About the company
ITM is a series E company based in Munich (Germany), founded in 2004 by . It operates as a Developer of radiopharmaceuticals and radioisotopes for cancer treatment. ITM has raised $681M in funding from investors like Temasek, and Petrichor. The company has 49 active competitors, including 23 funded and 8 that have exited. Its top competitors include companies like Advanced Accelerator Applications, SOFIE and Mariana Oncology.
Company Details
Developer of radiopharmaceuticals and radioisotopes for cancer treatment. The company's lead product is radionuclide therapy candidate LuCaFab (ITM-31) for the treatment of malignant brain tumors. The company offers medical isotopes like EndolucinBeta and TOCscan. It also offers radiolabelling and quality control equipment like iQS - Theranostics Synthesizer, iQS Ga-68, Fluidic Labeling, Module Reagent Set Manual, and 177Lu Labeling.
- Website
- Social
- Email ID
- @itm-radiopharma.com
- Phone Number
- +49
Key Metrics
Founded Year
2004
Location
Munich, Germany
Stage
Series E
Total Funding
in 8 rounds
Latest Funding Round
Investors
Ranked
2nd among 49 active competitors
Annual Revenue
as on Dec 31, 2019
Employee Count
as on Dec 31, 2023
Similar Companies
Legal entities associated with ITM
ITM is associated with 1 legal entity given below:
Legal Entity Name | Date of incorporation | Revenue | Net Profit | Employee Count |
|---|---|---|---|---|
Dec 01, 2004 | - | 707 | 143 |
Get your free copy of ITM's company profile
ITM's funding and investors
ITM has raised a total funding of $681M over 8 rounds. Its first funding round was on Jun 01, 2009. Its latest funding round was a Series E round on Jun 06, 2024 for $204M. 5 investors participated in its latest round, which includes Temasek, BlackRock, European Investment Bank and Nextech Invest.
Here is the list of recent funding rounds of ITM:
Date of funding | Funding Amount | Round Name | Post money valuation | Revenue multiple | Investors |
|---|---|---|---|---|---|
Jun 06, 2024 | $204M | Series E | 2456094 | 5615301 | |
Jun 05, 2023 | $273M | Series E | 4425458 | 7975148 | Temasek, Nextech Invest, and |
Mar 22, 2022 | $36.4M | Series D | 6183878 | 6780211 |
Access funding benchmarks and valuations. Sign up today!View details of ITM's funding rounds and investors
ITM's founders and board of directors
The founders of ITM is . is the CEO of ITM.
View details of ITM's Founder profiles and Board Members
ITM's Competitors and alternates
Top competitors of ITM include Advanced Accelerator Applications, SOFIE and Mariana Oncology. Here is the list of Top 10 competitors of ITM, ranked by ÃØÃÜÑо¿Ëù score :
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | ÃØÃÜÑо¿Ëù Score |
|---|---|---|---|---|---|
1st |  Advanced Accelerator Applications 2002, Saint Genis Pouilly (France), Acquired | Novartis company, developing molecular nuclear medicine theranostics | $56.1M | Vivo Capital, HBM PartnersÌý&²¹³¾±è;Ìý | 82/100 |
2nd |  2004, Munich (Germany), Series E | Developer of radiopharmaceuticals and radioisotopes for cancer treatment | $681M | 63/100 | |
3rd |  SOFIE 2008, Culver City (United States), Series C | Developer of molecular imaging systems and radio-pharmaceuticals | $38.1M | , Trilantic Capital Partners North AmericaÌý&²¹³¾±è;Ìý | 66/100 |
4th |  Mariana Oncology 2020, Watertown (United States), Acquired | Developer of radiopharmaceuticals for solid tumors | $250M | Atlas Venture, RA Capital ManagementÌý&²¹³¾±è;Ìý | 63/100 |
5th | Radiopharmaceutical company developing targeted alpha therapies for cancer treatment | $129M | Abingworth, SV Health InvestorsÌý&²¹³¾±è;Ìý | 63/100 | |
6th | Lantheus 2008, Billerica (United States), Public | Developer of diagnostic imaging agents and targeted therapeutics | - | 62/100 | |
7th |  Ariceum Therapeutics 2021, Berlin (Germany), Series A | Developer of drugs for systemic targeted radiation therapy to treat cancer | $51.6M | 62/100 | |
8th |  Alpha-9 Oncology 2018, Boston (United States), Series C | Developer of radiopharmaceuticals for the treatment of cancer | $261M | RA Capital Management, Janus Henderson InvestorsÌý&²¹³¾±è;Ìý | 59/100 |
9th |  ARTBIO 2021, Sacramento (United States), Series A | Develoer of alpha radioligand therapies for cancer treatment | $113M | Omega Funds, F-Prime CapitalÌý&²¹³¾±è;Ìý | 59/100 |
10th | Developer of radiotheranostics that facilitates life-enhancing treatments for patients | $148M | 57/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on ITM's competitors? Click to see the top ones
ITM's Investments and acquisitions
ITM has made no investments or acquisitions yet.
Reports related to ITM
Here is the latest report on ITM's sector:
View
News related to ITM
Media has covered ITM for a total of 18 events in the last 1 year, 7 of them have been about company updates and 6 about people movement.
•
GlobeNewswire•Apr 09, 2025•ITM
•
•
GlobeNewswire•Mar 13, 2025•ITM
•
Pharmaceutical Technology•Mar 06, 2025•ITM
•
EndPoints News•Mar 06, 2025•ITM
•
GlobeNewswire•Feb 25, 2025•ITM
•
Clinical Trials Arena•Jan 28, 2025•ITM
•
GlobeNewswire•Jan 28, 2025•ITM
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Frequently asked questions about ITM
When was ITM founded?
ITM was founded in 2004.Where is ITM located?
ITM is located in Munich, Germany.Is ITM a funded company?
ITM is a funded company, its first funding round was on Jun 01, 2009.When was the latest funding round of ITM?
ITM's latest funding round was on Jun 06, 2024.What is the annual revenue of ITM?
Annual revenue of ITM is €44²Ñ as on Dec 31, 2019.Our Lite Plan Awaits you - Its Free!
Sign up now to unlock full access to curated data
4M+ Companies- 212K+ Investors
- 580K+ Funding Rounds
- 207K+ Acquisitions
- 2.9K+ Sectors
- 57K+ Business Models
Are you a Founder ?
Explore our recently published companies
- withpi - San Francisco based, Unfunded company
- ElseWare - Crawley based, 1995 founded, Acquired company
- StrikeIT - Lucknow based, 2020 founded, Unfunded company
- InfySEC - Chennai based, 2010 founded, Unfunded company
- BeyondTax - Hyderabad based, 2023 founded, Unfunded company
- Session Mate - Gurugram based, 2025 founded, Unfunded company
